An unprecedented look at colorectal cancer
The maps, described in Cell, layer extensive molecular information on top of histological features to provide new information about the structure of the cancer, as well as how it forms, progresses, and interacts with the immune system.
The team at Harvard Medical School combined histology with single‑cell imaging technologies to construct large‑scale 2‑D and 3‑D spatial maps of colorectal cancer. The resulting atlases, described in the journal *Cell*, layer extensive molecular information on top of histological features, revealing novel structural details, immune‑microenvironment heterogeneity, and dynamic transitions within individual tumors. These comprehensive maps aim to advance research, improve diagnosis, and guide precision‑medicine strategies for colorectal cancer patients.
By integrating traditional histology with multiplexed single‑cell imaging, the atlases allow researchers to visualize and quantify previously inaccessible spatial and molecular heterogeneity within colorectal tumors, offering insights that could refine diagnostic grading, prognostic markers, and therapeutic targeting of immune interactions.
Evidence level: Irányelv / elfogadott gyakorlat. Magas szintű klinikai elfogadottság.
Related signals
- Encorafenib, Binimetinib, and Cetuximab in BRAF V600E‑Mutated Colorectal Cancer
- Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review
- Three Versus 6 Months of Adjuvant Oxaliplatin‑Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT—An International, Randomized, Phase III, Noninferiority Trial
- Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
- Emerging and Established Targets in Colorectal Cancer: Translating Biology Into Therapeutics